Abstract
Chronic obstructive pulmonary disease (COPD) is one of the most severe public health problems and a leading cause of death worldwide. One of the main reasons for poor control of the disease is low patient compliance with treatment plan. The aim of the study was to investigate sociodemographic and health status factors that may have an influence on adherence to treatment. There were 106 inpatients (F/M, 42/64; mean age 70 ± 6 years) with COPD enrolled into this retrospective study. Patients completed the Adherence to Refills and Medications Scale (ARMS) to assess adherence to therapy. We found that the mean ARMS score was 23.1 ± 6.8. About 86% of patients had low adherence, and 14% had good adherence (mean score 3.2 ± 2.4). The low-adherence patients were more likely to be older (p = 0.020), female (p = 0.011), single (p = 0.019), not professionally active (p = 0.049), hospitalized more often (p = 0.005) and for a longer time (p = 0.046), feel worse (p = 0.023), experience a greater impact of the disease on sleep quality (p = 0.008) and daily activities (p = 0.001), and had a higher GOLD stage of COPD when compared to patients with good adherence patients (p = 0.012). Multiple factor analysis demonstrates that independent adverse predictors of the ARMS score included the following: being single (OR = 3.18), having had more than eight hospitalizations (OR = 1.18), and experiencing dysfunction in daily activities (OR = 1.79). Male gender (OR = 0.77) and longer than 21-day hospitalizations (OR = 0.93) were independent positive predictors of adherence. In conclusion, COPD patients demonstrate a low level of adherence to pharmacotherapy. Adherence is adversely affected by sociodemographic (older age, female gender, being single, and professionally inactive) and clinical factors (more frequent hospitalizations, perception of poor well-being, disordered sleep and daily functioning, and a higher GOLD stage).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bourbeau J, Bartlett SJ (2008) Patient adherence in COPD. Thorax 63(9):831–838
Burkhart PV, Sabaté E (2003) Adherence to long–term therapies: evidence for action. J Nurs Scholarsh 35(3):207
Duarte–de–Araújo A, Teixeira P, Hespanhol V, Correia–de–Sousa J (2018) COPD: understanding patients’ adherence to inhaled medications. Int J Chron Obstruct Pulmon Dis 13:2767–2773
Ivanov Y, Nikolaev I, Nemeth I (2018) Real–life evaluation of COPD treatment in a Bulgarian population: a 1–year prospective, observational, noninterventional study. Int J Chron Obstruct Pulmon Dis 13:653–663
Ji H, Fang L, Yuan L, Zhang Q (2019) Effects of exercise–based cardiac rehabilitation in patients with acute coronary syndrome: a meta–analysis. Med Sci Monit 25:5015–5027
Jouleh B, Erdal M, Eagan TM, Bakke P, Gulsvik A, Nielsen R (2018) Guideline adherence in hospital recruited and population based COPD patients. BMC Pulm Med 1:195
Kardas P, Czeleko T, Śliwczyński A (2012) Consistency and regularity of the COPD and asthma treatment in Poland – the adherence to therapeutic recommendations according to the national database of the prescription collection. In: Proceedings of the 10th International Conference of the Polish Pharmacoeconomics Society – ISPOR Poland Chapter, Warsaw
Khdour MR, Hawwa AF, Kidney JC, Smyth BM, McElnay JC (2012) Potential risk factors for medication non–adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol 68(10):1365–1373
Kokturk N, Polatli M, Oguzulgen IK, Saleemi S, Al Ghobain M, Khan J, Doble A, Tariq L, Aziz F, El Hasnaoui A (2018) Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study. Int J Chron Obstruct Pulmon Dis 13:1377–1388
Kripalani S, Risser J, Gatti ME, Jacobson TA (2009) Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low–literacy patients with chronic disease. Value Health 12(1):118–123
Le LAK, Johannessen A, Hardie JA, Johansen OE, Gulsvik A, Vikse BE, Bakke P (2019) Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort. Int J Chron Obstruct Pulmon Dis 14:1639–1655
Leiva–Fernández J, Leiva–Fernández F, García–Ruiz A, Prados–Torres D, Barnestein–Fonseca P (2014) Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial. BMC Pulm Med 14:70
Liao KM, Chen CY (2019) The association between adherence and dementia in chronic obstructive pulmonary disease. Medicine (Baltimore) 98(20):e15646
Lomper K, Chabowski M, Chudiak A, Białoszewski A, Dudek K, Jankowska–Polańska B (2018) Psychometric evaluation of the Polish version of the Adherence to Refills and Medications Scale (ARMS) in adults with hypertension. Patient Prefer Adherence 12:2661–2670
López-Campos JL, Tan VV, Soriano JB (2016) Global burden of COPD. Respirology 21(1):14–23
Mäkelä MJ, Backer V, Hedegaard M, Larsson K (2013) Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med 107(10):1481–1490
Müllerová H, Landis SH, Aisanov Z, Davis KJ, Ichinose M, Mannino DM, Maskell J, Menezes AM, van der Molen T, Oh YM, Tabberer M, Han MK (2016) Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey. Int J Chron Obstruct Pulmon Dis 11:881–890
Niżankowska–Mogilnicka E, Mejza F, Buist AS, Vollmer WM, Skucha W, Harat R, Pajak A, Gasowski J, Frey J, Nastalek P, Twardowska M, Janicka J, Szczeklik A (2007) Prevalence of COPD and tobacco smoking in Malopolska region – results from the BOLD Study in Poland. Pol Arch Intern Med 117(9):402–409
R Core Team (2019) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R–project.org. Accessed on 16 Feb 2020
Rand CS, Nides M, Cowles MK, Wise RA, Connett J (1995) Long–term metered–dose inhaler adherence in a clinical trial. The lung health study research group. Am J Respir Crit Care Med 152(2):580–588
Sanduzzi A, Balbo P, Candoli P, Catapano GA, Contini P, Mattei A, Puglisi G, Santoiemma L, Stanziola AA (2014) COPD: adherence to therapy. Multidiscip Respir Med 9(1):60
Shrestha R, Pant A, Shakya Shrestha S, Shrestha B, Gurung RB, Karmacharya BM (2015) A cross–sectional study of medication adherence pattern and factors affecting the adherence in chronic obstructive pulmonary disease. Kathmandu Univ Med J 13(49):64–70
Tashkin DP (1995) Multiple dose regimens. Impact on compliance. Chest 107(5 Suppl):176S–182S
Turner J, Wright E, Mendella L, Anthonisen N (1995) Predictors of patient adherence to long–term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent positive pressure breathing. Chest 108(2):394–400
van der Molen T, Pieters W, Bellamy D, Taylor R (2002) Measuring the success of treatment for chronic obstructive pulmonary disease – patient, physician and healthcare payer perspectives. Respir Med 96(Suppl C):S17–S21
Vestibo J, Anderson JA, Calverley P, Celli B, Ferguson GT, Jenkins C, Knobil K, Willits LR, Yates JC, Jones PW (2009) Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 64(11):939–943
Vos T, Flaxman AD, Naghavi M et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010; a systematic analysis for the Global Burden of Disease study 2010. Lancet 380(9859):2163–2196
Wiśniewski D, Porzezińska M, Gruchała–Niedoszytko M, Niedoszytko M, Słomiński JM, Jassem E (2014) Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations. Pneumonol Alergol Pol 82(2):96–104
Acknowledgments
The authors thank all of the patients who participated in the survey. This study received no external funding.
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of Wroclaw Medical University (approval no. 371/2019).
Informed Consent
Written informed consent was obtained from all individual participants included in the study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Polański, J., Chabowski, M., Świątoniowska-Lonc, N., Mazur, G., Jankowska-Polańska, B. (2020). Medication Compliance in COPD Patients. In: Pokorski, M. (eds) Health and Medicine. Advances in Experimental Medicine and Biology(), vol 1279. Springer, Cham. https://doi.org/10.1007/5584_2020_508
Download citation
DOI: https://doi.org/10.1007/5584_2020_508
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-51120-3
Online ISBN: 978-3-030-51121-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)